|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 271, Issue 6 2515-H2519, Copyright © 1996 by American Physiological Society
ARTICLES |
M. Tani, H. Hasegawa, Y. Suganuma, K. Shinmura, Y. Kayashi and Y. Nakamura
Department of Geriatric Medicine, Keio University School of Medicine, Tokyo, Japan.
Protection of the ischemic myocardium by pretreatment with a high dose of 2,3-butanedione monoxime (BDM) is attributed to the enhancement of glycolytic ATP production rather than to the inhibition of contracture during mild ischemia. Our objective was to investigate whether the inhibition of contracture would protect the arrested heart during prolonged ischemia. Isolated perfused rat hearts were subjected to 30 min of low-flow ischemia followed by reperfusion. Ischemic hearts were treated with BDM (5 mmol/l) after beating stopped. BDM ameliorated the increase in intraventricular pressure after ischemia without significant changes in ATP levels and with a decreased accumulation of lactate. BDM treatment accelerated the recovery of function and high-energy phosphates with reduced myocardial Ca2+ overload. The results of this study suggested that inhibition of contracture can protect the heart from ischemia-reperfusion injury.
This article has been cited by other articles:
![]() |
M. E. Reichelt, L. Willems, J. N. Peart, K. J. Ashton, G. P. Matherne, M. R. Blackburn, and J. P. Headrick Heart/Cardiac Muscle: Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine Exp Physiol, January 1, 2007; 92(1): 175 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kido, H. Otani, S. Kyoi, T. Sumida, H. Fujiwara, T. Okada, and H. Imamura Ischemic preconditioning-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contraction-induced myocardial injury Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H81 - H90. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zou, S. Sasaguri, K. G. Rajesh, and R. Suzuki dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1968 - H1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Warnecke, B. Schulze, C. Hagl, A. Haverich, and U. Klima Improved right heart function after myocardial preservation with 2,3-butanedione 2-monoxime in a porcine model of allogenic heart transplantation J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 81 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sanbe, J. Gulick, E. Hayes, D. Warshaw, H. Osinska, C.-B. Chan, R. Klevitsky, and J. Robbins Myosin light chain replacement in the heart Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1355 - H1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Stapleton, C. M. Fuchsbauer, and A. P. Allshire BDM drives protein dephosphorylation and inhibits adenine nucleotide exchange in cardiomyocytes Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1260 - H1266. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |